Strategic collaborations BIOASTER actively leads and participates in multi-stakeholder partnerships with academic institutions, startups, SMEs and industrial groups, presenting opportunities to offer diagnostic tools, assay development support, and technology transfer services to collaborative projects.

AMR and diagnostics focus The institute prioritizes antimicrobial resistance, vaccine safety and efficacy, and rapid bedside diagnostics, signaling demand for partnerships in molecular diagnostics, multiplex assays, and point-of-care testing solutions.

Global access and expansion With operations in Lyon and Paris and a diverse international team, BIOASTER targets global health challenges, suggesting sales potential for cross-border tech licensing, service contracts, and international joint development programs.

Industry network Backed by a broad consortium including Lyonbiopôle, CNRS, INSERM, CEA, Mérieux Institute, Danone Nutricia Research, Sanofi Pasteur and bioMérieux, there are ample channels for co-development, pilot programs, and procurement opportunities.

Recent partnerships Recent collaborations with Qiagen, Zynnon, PharmaLex and NIH indicate a receptiveness to diagnostic platform integrations and regulatory/clinical collaboration, suggesting opportunities to offer compatible assays, workflow optimization, and regulatory support services.